All In MedTech

FDA Clearance Tracker · P100010-S110

Arctic Front Advance and Arctic Front Advance Pro Cryoablation Catheter

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Jun 18, 2021 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Jun 18, 2021

Approved

Time to decision

231 days

Received Oct 30, 2020. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Panel Track

Device class

Class III

The decision

FDA number
P100010-S110
Device name
Arctic Front Advance and Arctic Front Advance Pro Cryoablation Catheter
Applicant location
Mounds View, MN
Received
Oct 30, 2020
Decided
Jun 18, 2021
Decision
Approved
Supplement type
Panel Track
Reason for supplement
Labeling Change - Indications/instructions/shelf life/tradename
Original approval
P100010

Device type

Device class
Class III

Every decision under product code OAE

FDA's approval statement

As written in FDA's record.

Approval for expanding the indications to include the treatment of recurrent symptomatic paroxysmal atrial fibrillation as an alternative to antiarrhythmic drug therapy as an initial rhythm control strategy.

Source documents

Other decisions for Medtronic Cryocath, LP

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

4 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.